Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,566 | -11,969 | -8,132 | -3,326 | -9,914 |
| Depreciation Amortization | 63 | 44 | 26 | 13 | 30 |
| Other Working Capital | 1,926 | 2,294 | 2,085 | 950 | -228 |
| Other Operating Activity | 565 | 555 | 323 | 152 | 1,032 |
| Operating Cash Flow | $-13,013 | $-9,076 | $-5,699 | $-2,211 | $-9,080 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -11 | -11 | N/A | -125 |
| Investing Cash Flow | $-25 | $-11 | $-11 | $N/A | $-125 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,351 | 11,351 | 11,351 | 11,416 | 23,448 |
| Other Financing Activity | -253 | -179 | -129 | -64 | -201 |
| Financing Cash Flow | $11,098 | $11,171 | $11,221 | $11,351 | $23,247 |
| Beginning Cash Position | 20,208 | 20,208 | 20,208 | 20,208 | 6,166 |
| End Cash Position | 18,268 | 22,292 | 25,720 | 29,349 | 20,208 |
| Net Cash Flow | $-1,940 | $2,084 | $5,511 | $9,141 | $14,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,013 | -9,076 | -5,699 | -2,211 | -9,080 |
| Capital Expenditure | -25 | -11 | -11 | N/A | -125 |
| Free Cash Flow | -13,038 | -9,088 | -5,710 | -2,211 | -9,205 |